Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.23.1
Balance Sheet Components
 3 Months Ended
Mar. 31, 2023
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2022 and March 31, 2023 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2022     2023  
             
Prepaid directors and officers’ liability insurance premiums   $ 476     $   337  
Prepaid preclinical services     1,554       1,196  
Other     159       319  
Total   $ 2,189     $ 1,852  

 

Property, plant and equipment as of December 31, 2022 and March 31, 2023 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2022     2023  
             
Leasehold improvements   $       15     $            15  
Furniture and fixtures     14       14  
Subtotal     29       29  
Less accumulated depreciation     (7 )     (8 )
Net   $ 22     $ 21  

 

Accounts payable as of December 31, 2022 and March 31, 2023 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2022     2023  
             
Trade accounts payable   $ 846     $ 610  
Credit card liability     46       180  
Total   $ 892     $ 790  

 

Accrued liabilities as of December 31, 2022 and March 31, 2023 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     March 31,  
    2022     2023  
             
Accrued labor costs   $ 1,487     $ 610  
Accrued drug development costs     228       766  
Other     522       322  
Total   $ 2,237     $ 1,698